PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person)

ApprovedActive
0 views this week 0 watching Active
Interest: 41/100
41
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

H. Pylori Infection

Conditions

H. Pylori Infection, Gastric Cancer, Gastritis H Pylori

Trial Timeline

Nov 6, 2024 → Nov 6, 2027

About PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person)

PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) is a approved stage product being developed by Phathom Pharmaceuticals for H. Pylori Infection. The current trial status is active. This product is registered under clinical trial identifier NCT07224048. Target conditions include H. Pylori Infection, Gastric Cancer, Gastritis H Pylori.

What happened to similar drugs?

2 of 4 similar drugs in H. Pylori Infection were approved

Approved (2) Terminated (0) Active (2)

Hype Score Breakdown

Clinical
20
Activity
12
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT07224048ApprovedActive